Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A **micelle** is a colloidal aggregate of amphipathic molecules—such as bile salts or phospholipids—that spontaneously forms in aqueous environments when the concentration of these molecules exceeds the critical micelle concentration[1][2][3][8]. In the context of the intestine, **intestinal micelles** refer to small, spherical structures formed by bile salts and phospholipids during the digestion of dietary fats[2][5]. Their hydrophilic "head" groups face outward toward water, while their hydrophobic "tail" groups aggregate inward, trapping insoluble lipid digestion products like fatty acids and monoglycerides in the core[1][3][7]. Micelles are essential not as discrete molecular drug targets but as supramolecular carriers; they carry hydrophobic molecules across the unstirred water layer of the intestinal lumen, enabling their absorption by enterocytes (intestinal epithelial cells)[4][5][6]. Thus, **micelles themselves are not receptors, enzymes, transporters, or typical drug targets, but are physical structures vital for lipid absorption**. They are about 200 times smaller than emulsion droplets and can efficiently deliver their lipid contents for absorption[6]. The process of micelle formation is termed *micellization*, and it is a physical phenomenon, not controlled by a single gene or protein target[1][3]. **Intestinal micelles** are relevant for physiological and nutritional science but do not represent a target molecule or receptor that could be used for direct pharmacological intervention; instead, they are intermediates in fat digestion crucial for enabling the transfer and absorption of dietary fats in the intestine[4][5][2].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Micelle (null).